Media Summary: This is the fifth in a series of videos designed to let patients, caregivers, and patient advocates know that FDA wants to hear from ... History doesn't repeat itself, the uninformed do. Get every side of every story at Subscribe for 40% off ... J. Paul Phillips provides an overview of the FDA's

Expanded Access - Detailed Analysis & Overview

This is the fifth in a series of videos designed to let patients, caregivers, and patient advocates know that FDA wants to hear from ... History doesn't repeat itself, the uninformed do. Get every side of every story at Subscribe for 40% off ... J. Paul Phillips provides an overview of the FDA's An overview on the submission process for emergency and non-emergency As part of our Speaker Series, we sat down with ethicist Holly Fernandez Lynch from University of Pennsylvania to discuss how ... On Rare Disease Day 2017 at Capitol Hill, we spoke with Jaswinder Khera, US Managing Director of WEP Clinical who provided ...

Our latest video features Tobias Polak, the director of Real-World Data at myTomorrows and a PhD candidate focusing on ... Interview with Dr. Adnan Jaigirdar, MD, FACS of the FDA discussing Ax-S Pharma is on a mission to support life science companies, health systems, and patients who want to The first of our series of educational videos on pre-approval

Photo Gallery

Expanded Access
Expanded Access Part 1: Introduction
What is Expanded Access?
Patients Matter: What is Expanded Access?
She Humiliated the Arab Empire
Expanded Access Programs (Compassionate Use)
Overview of FDA's Expanded Access Program (13/14) REdI 2017
Expanded Access Part 2: How to Submit a Single Patient IND
Early Access Programs - All You Need To Know | myTomorrows
Speaker Series: Right to Try - Expanded Access
WEP Clinical - Expanded Access Programs
Expanded Access as a source of real-world data: An overview of FDA and EMA approvals
Sponsored
Sponsored
View Detailed Profile
Expanded Access

Expanded Access

Expanded access

Expanded Access Part 1: Introduction

Expanded Access Part 1: Introduction

What is

Sponsored
What is Expanded Access?

What is Expanded Access?

This week's briefing focuses on

Patients Matter: What is Expanded Access?

Patients Matter: What is Expanded Access?

This is the fifth in a series of videos designed to let patients, caregivers, and patient advocates know that FDA wants to hear from ...

She Humiliated the Arab Empire

She Humiliated the Arab Empire

History doesn't repeat itself, the uninformed do. Get every side of every story at https://ground.news/night. Subscribe for 40% off ...

Sponsored
Expanded Access Programs (Compassionate Use)

Expanded Access Programs (Compassionate Use)

Expanded Access

Overview of FDA's Expanded Access Program (13/14) REdI 2017

Overview of FDA's Expanded Access Program (13/14) REdI 2017

J. Paul Phillips provides an overview of the FDA's

Expanded Access Part 2: How to Submit a Single Patient IND

Expanded Access Part 2: How to Submit a Single Patient IND

An overview on the submission process for emergency and non-emergency

Early Access Programs - All You Need To Know | myTomorrows

Early Access Programs - All You Need To Know | myTomorrows

What is an

Speaker Series: Right to Try - Expanded Access

Speaker Series: Right to Try - Expanded Access

As part of our Speaker Series, we sat down with ethicist Holly Fernandez Lynch from University of Pennsylvania to discuss how ...

WEP Clinical - Expanded Access Programs

WEP Clinical - Expanded Access Programs

On Rare Disease Day 2017 at Capitol Hill, we spoke with Jaswinder Khera, US Managing Director of WEP Clinical who provided ...

Expanded Access as a source of real-world data: An overview of FDA and EMA approvals

Expanded Access as a source of real-world data: An overview of FDA and EMA approvals

Our latest video features Tobias Polak, the director of Real-World Data at myTomorrows and a PhD candidate focusing on ...

Expanded Access

Expanded Access

Expanded Access

FDA's Expanded Access for Treatment Use

FDA's Expanded Access for Treatment Use

This video covers the FDA's

Expanded Access Overview

Expanded Access Overview

Access

MesoTV | Conversation with the FDA regarding Expanded Access, Compassionate Use for mesothelioma

MesoTV | Conversation with the FDA regarding Expanded Access, Compassionate Use for mesothelioma

Interview with Dr. Adnan Jaigirdar, MD, FACS of the FDA discussing

Group Expanded Access vs Individual Compassionate Use (Ax-S Pharma)

Group Expanded Access vs Individual Compassionate Use (Ax-S Pharma)

Expanded Access

What is Expanded Access? How EA Programs Help in the Development of New Vaccines - Ax-S Pharma

What is Expanded Access? How EA Programs Help in the Development of New Vaccines - Ax-S Pharma

Ax-S Pharma is on a mission to support life science companies, health systems, and patients who want to

Expanded Access Care Webinar

Expanded Access Care Webinar

An introduction to and overview on the

Expanded Access To New Medicines:  How it Works in the U.S.

Expanded Access To New Medicines: How it Works in the U.S.

The first of our series of educational videos on pre-approval

Related Video Content

Expanded Access | FDA - U.S. Food and Drug Administration information

Learn about expanded access, including information about the different types of expanded access, how to submit...

21 CFR Part 312 Subpart I -- Expanded Access to Investigational … information

FDA may ask a sponsor to consolidate expanded access under this section when the agency has received a significant...

What Is Expanded Access and How Does It Work? - ScienceInsights information

Apr 28, 2026 · Expanded access is a pathway that allows patients with serious or life-threatening conditions to use...

Expanded access - Wikipedia information

Expanded access or compassionate use is the use of an unapproved drug or medical device under special forms of...

Expanded Access 2025: Key Takeaways from FDA’s Q&A Guidance information

Nov 11, 2025 · The US FDA has a long history of facilitating expanded access (EA) to promising new investigational...